WO2010033074 Use of a TLR7 agonist for the treatment of cancer
| Steps | Conditions | Reactions |
| a |
1. Butylamine / DIEA 2. TFA / MeOH |
Secondary amine deprotection (nucleophilic substitution) / THP deprotection |
| b | 2-chloro-5-chloromethylpyridine / K2CO3 / DMF | Nucleophilic substitution |
| c |
1. Br2 / CHCl3:MeOH 100:1 2. HCl 12N |
Oxidation |
| d | Dimethylaminoethanol / NaH / dioxane | Ether synthesis (nucleophilic substitution) |